Newmark, J., Wrighton, P., Iovino, S., Amin, P., Thompson, M., Rizal, S., Bilodeau, M., Dong, R., Zhen, W., Raghav, J., Jaskolka, M., Diner, B., Soman, V., Jinadasa, T., Apte, A., Wu, M., Bottega, S., Thakkar, M., Agosto, L., Majithia, D., Jambard, S., Jansson-Fritzberg, L., Jones, M., Fletcher, J., Weiss, M., Kaye, E., Steward, B., Bochicchio, J., Pietrasiewicz, S., Rubio, E. M., Phan, H. T., Chander, N., Kazemian, M., Lam, K., Reid, S., Dinsmore, M., Teslovich, T., Xie, J., Gupta, A., Burkly, L. (2025). Abstract 4364195: A transformative LDL cholesterol–lowering
                    <i>in vivo</i>
                    CRISPR gene editing medicine that functionally upregulates LDLR in mice and non-human primates. Circulation. https://doi.org/10.1161/circ.152.suppl_3.4364195